Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.
Meitar represented New York/London-based private equity firm Rhone Capital LLC in its acquisition of the European and Israeli operations of Eden Springs for approximately $90 million, based on an enterprise value of Euro 300 million.
Meitar represented Stratasys Ltd. (SSYS) in a public offering of ordinary shares for approximately $481M on NASDAQ with JP Morgan as sole-book-runner and Piper Jaffray, Morgan Stanley, Bank of America Merrill Lynch and Needham as co-managers.
Meitar represented a leading 3D printing company, Stratasys, Ltd. (NASDAQ:SSYS) in its acquisition of MakerBot, the Brooklyn NY-based leader in desktop 3D printing, in a stock-for-stock swap, valued at approximately $403 million, with additional contingent performance-based payments valued at approximately $201M.
Our firm represented ROTH Capital partners in the $20 million follow on offering by Attunity Ltd. on NASDAQ.
